
Agilent Technologies A
€ 98.59
-0.31%
Quartalsbericht 2025-Q4
hinzugefügt 03.03.2026
Agilent Technologies DPO 2011-2026 | A
DPO Jährlich Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 50.1 | 51.6 | 54.8 | 55.7 | 54 | 46.8 | 51 | 51.2 | 48.6 | 51.7 | 55.8 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 55.8 | 46.8 | 51.9 |
DPO Vierteljährlich Agilent Technologies
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62.8 | - | 57.8 | 63.4 | - | - | - | 54.9 | 63 | - | - | 55.1 | 54.2 | - | 53.6 | 49.9 | 49.1 | 17.9 | 53 | 50.9 | 52.9 | 18.7 | 55.5 | 51.8 | 53.6 | 18.8 | 57.2 | 49.4 | 53 | 18.3 | 53.7 | 49.6 | 47.1 | 15.8 | 46.7 | 48 | 47.7 | 17 | 50.8 | 67 | 67.1 | 18.3 | 54.4 | 68.6 | 50.5 | 16.2 | 49.5 | 46.5 | 53.2 | 17.5 | 50.5 | 50.7 | 59.5 | 18.9 | 53.9 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 68.6 | 15.8 | 46.5 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 1.63 | -1.52 % | $ 2.17 M | ||
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Illumina
ILMN
|
56.3 | $ 126.83 | -1.31 % | $ 20.2 B | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 24.61 | -1.48 % | $ 684 M | ||
|
Lantheus Holdings
LNTH
|
23.6 | $ 82.83 | -1.52 % | $ 5.59 B | ||
|
National Research Corporation
NRC
|
10.1 | $ 16.85 | -1.52 % | $ 377 M | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 22.39 | 2.47 % | $ 1.19 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Precipio
PRPO
|
23.9 | $ 31.9 | 2.9 % | $ 51.2 M | ||
|
Personalis
PSNL
|
67.3 | $ 5.43 | -8.89 % | $ 322 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Senseonics Holdings
SENS
|
68 | $ 7.15 | -1.72 % | $ 298 M | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 15.19 | -2.63 % | $ 459 M | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Thermo Fisher Scientific
TMO
|
49.3 | $ 470.48 | 0.52 % | $ 177 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 166.04 | -3.03 % | $ 8.23 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Trinity Biotech plc
TRIB
|
163 | $ 0.63 | -2.99 % | $ 61.9 M | ||
|
Guardant Health
GH
|
48.6 | $ 83.59 | -5.55 % | $ 10.5 B | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | $ 59.97 | -1.7 % | $ 3.59 B | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
33 | $ 1.93 | - | $ 8.54 M | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 415.77 | -1.33 % | $ 12 B | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
32.4 | $ 2.19 | 0.23 % | $ 5.03 M | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 101.26 | -1.89 % | $ 8.35 B | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 260.26 | -1.2 % | $ 21.7 B | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.22 | -2.49 % | $ 2 B | ||
|
NeoGenomics
NEO
|
19.7 | $ 8.96 | 4.01 % | $ 1.15 B | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 4.88 | 1.04 % | $ 452 M | ||
|
Natera
NTRA
|
17.9 | $ 202.48 | -0.93 % | $ 19.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 195.25 | -0.7 % | $ 21.7 B | ||
|
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
95 | - | -16.95 % | $ 1.54 M |